Morning Seminar September 27, 2007

J Clin Oncol. 2007 Sep 20;25(27):4239-45.
Reduction of health status 7 years after addition of chemotherapy to craniospinal irradiation for medulloblastoma: a follow-up study in PNET 3 trial survivors on behalf of the CCLG (formerly UKCCSG).
Bull KS, Spoudeas HA, Yadegarfar G, Kennedy CR; CCLG.

Morning Seminar September 20, 2007

Bone Marrow Transplant. 2007 Mar;39(5):269-78.
Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+ CD3+ count reconstitution is associated with survival.
Koehl U, Bochennek K, Zimmermann SY, Lehrnbecher T, Sörensen J, Esser R, Andreas C, Kramm C, Grüttner HP, Falkenberg E, Orth A, Bader P, Schwabe D, Klingebiel T.

Morning Seminar September 13, 2007

Clin Rheumatol. 2007 Aug;26(8):1332-4.
Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis.
Jelusić M, Lukić IK, Tambić-Bukovac L, Dubravcić K, Malcić I, Rudan I, Batinić D.

Morning Seminar September 11, 2007

Blood. 2007 Sep 15;110(6):1924-32.
Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia.
Rezvani K, Yong AS, Savani BN, Mielke S, Keyvanfar K, Gostick E, Price DA, Douek DC, Barrett AJ.

Morning Seminar September 6, 2007

Bone Marrow Transplant. 2007 Sep;40(5):473-80.
Infliximab for GVHD therapy in children.
Sleight BS, Chan KW, Braun TM, Serrano A, Gilman AL.

Morning Seminar September 4, 2007

Blood. 2007 Sep 1;110(5):1458-65.
The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA.
Ganapathi KA, Austin KM, Lee CS, Dias A, Malsch MM, Reed R, Shimamura A.